Irvine, CA, United States of America

David Searl Kimball

This inventor holds 9 USPTO granted patents and 2 published patent applications and 5 EPO patents. Top assignees: Zoll Circulation, Incorporated, Medtronic Minimed, Inc.. Active years: 2005-2023.

USPTO Granted Patents = 9 

% Patents Active = 44.4

 

Average Co-Inventor Count = 2.1

ph-index = 4

Forward Citations = 109(Granted Patents)


Company Filing History:


Years Active: 2005-2023

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: David Searl Kimball: Innovator in Medical Fluid Connectors

Introduction

David Searl Kimball is a notable inventor based in Irvine, CA. He has made significant contributions to the field of medical technology, particularly in the development of fluid connectors. With a total of 9 patents to his name, Kimball's work has had a substantial impact on medical practices.

Latest Patents

Among his latest innovations is a system and method for effecting non-standard fluid line connections. This invention features a Luer-like non-standard quick disconnect medical fluid connector that cannot be engaged with a standard Luer fitting. This advancement is crucial for ensuring safety and efficiency in medical procedures.

Career Highlights

Throughout his career, Kimball has worked with prominent companies in the medical field, including Zoll Circulation, Incorporated and Medtronic Minimed, Inc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking technologies.

Collaborations

Kimball has collaborated with talented individuals such as Stelica Stelea and Lynn M Shimada. These partnerships have fostered innovation and creativity in his projects.

Conclusion

David Searl Kimball's contributions to medical technology through his patents and collaborations highlight his role as a significant inventor in the industry. His work continues to influence the development of safer medical devices.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…